Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Significances of Atropin Administration for the GLP-1 Potentiation of Glucose Induced Insulin Secretion and the Cephalic Insulin Response

NCT01534442 is registered in ClinicalTrials.gov with University Hospital, Gentofte, Copenhagen as lead sponsor.

NCT NCT01534442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01534442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Significances of Atropin Administration for the GLP-1 Potentiation of Glucose Induced Insulin Secretion and the Cephalic Insulin Response
Lead sponsor
University Hospital, Gentofte, Copenhagen
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2011
Completion date
December 31, 2012
Enrollment
10 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

the focus of this study is to evaluete the significances of the vagal cholinerg nervuos system for the effect of glp-1 by using atropin administration.